Please Wait
Applying Filters...
menu
    • menu
    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Arlanda is your partner for the Brazil market.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    xyz-pharma-m-2025-03-17

    Virtual Booth

    Contact Supplier

    Menu

    Apranax

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    DRUG PRODUCT COMPOSITIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 37Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    ANI Pharmaceuticals Announces FDA Approval Of Naproxen Delayed-Release Tablets
    ANI Pharmaceuticals Announces FDA Approval Of Naproxen Delayed-Release Tablets

    02 Jul 2024

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2024/07/02/2907285/0/en/ANI-Pharmaceuticals-Announces-the-FDA-Approval-and-Launch-of-Naproxen-Delayed-Release-Tablets-USP.html

    GLOBENEWSWIRE
    02 Jul 2024
    Share Share
    Novitium Pharma's Generic Naproxen Receives Approval in US
    Novitium Pharma's Generic Naproxen Receives Approval in US

    12 Jun 2024

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=218497

    FDA
    12 Jun 2024
    Share Share
    Enforcement Report - Week of December 6, 2023
    Enforcement Report - Week of December 6, 2023

    06 Dec 2023

    // FDA

    https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-december-6-2023-46648.pdf

    FDA
    06 Dec 2023
    Share Share
    Actavis' Biologic Naproxen (Esomeprazole Magnesium) Receives Approval in the U.S.
    Actavis' Biologic Naproxen (Esomeprazole Magnesium) Receives Approval in the U.S.

    24 Aug 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=204470

    FDA
    24 Aug 2022
    Share Share
    Hetero lab III's Generic Naproxen Receives Apprival in the U.S
    Hetero lab III's Generic Naproxen Receives Apprival in the U.S

    07 Jun 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215776

    FDA
    07 Jun 2022
    Share Share
    Labelling update regarding the use of NSAIDs beyond 20 weeks of pregnancy
    Labelling update regarding the use of NSAIDs beyond 20 weeks of pregnancy

    08 Jun 2021

    // NEWSWISE

    https://www.newswire.ca/news-releases/labelling-update-regarding-the-use-of-non-steroidal-anti-inflammatory-drugs-nsaids-beyond-20-weeks-of-pregnancy-and-risk-of-kidney-damage-to-unborn-babies-866562162.html

    NEWSWISE
    08 Jun 2021
    Share Share